Page 1735 - Cote clinical veterinary advisor dogs and cats 4th
P. 1735

Refeeding Syndrome  871.e3



            Phosphate (Potassium Phosphate)*                                       PROGNOSIS & OUTCOME
  VetBooks.ir  Serum Concentrations   Dosage †               Monitor Serum Levels  Guarded  to  good,  depending  on  underlying   Diseases and   Disorders
            (mmol/L)*
                                                                                  problem,  familiarity/recognition  of  the  syn-
                                                                                  drome,  level  of  patient  care,  and  severity  of
                                                             q 24h
            0.7-1
                                      0.01-0.03 mmol/kg/h
            0.5-0.7                   0.03-0.06 mmol/kg/h    q 12-24h             refeeding syndrome
            <0.5                      0.06-0.1 mmol/kg/h     q 6-12h               PEARLS & CONSIDERATIONS
                                        2−
                             +
           *Potassium phosphate = 4.4 mEq K /mL and 3 mmol PO 4 /mL. To convert to mg/dL, multiply the mmol/L value by 3.1.  Comments
           † Use caution with use in chronic kidney disease patients.
                                                                                  Although uncommon in veterinary patients, a
                                                                                  high index of suspicion for the syndrome should
                                                                                  be maintained for any nutritionally depleted
            Magnesium (Magnesium Sulfate or Chloride)*                            animal during the initial period (24 hours to
            Route    Dosage        Dosage          Dosage          Dosage         10 days) of refeeding. This is a potentially fatal
                                                                                  syndrome that can be prevented or ameliorated
            CRI      0.5-1 mEq/kg/day †  0.02-0.04 mEq/kg/h  6.15-12.3 mg/kg/day  0.25-0.5 mg/kg/h  by careful monitoring and prompt therapeutic
            Bolus    0.15-0.3 mEq/kg               20-30 mg/kg                    intervention.
           *The continuous-rate infusion (CRI) and bolus methods should be used with caution in chronic kidney disease. For kidney disease   Prevention
           patients, decrease dosage by 50%-75%.
           † 1 mEq = 12.3 mg,                                                     •  Identify fluid and electrolyte abnormalities,
                                                                                    and initiate correction before or at the same
                                                                                    time as instituting nutritional support.
                                                                                  •  Identify at-risk patients. For high-risk patients,
            Potassium Chloride*†‡                                                   consider thiamine, phosphorus, and potassium
            Serum Concentrations   mEq of KCl to Add    Maximal Fluid Infusion Rate  supplementation before nutritional support
            (mEq/L)                to 1 L of Fluid      (mL/kg/h)                   and for the first 24 hours of feeding.
                                                                                    ○   Thiamine is dosed as 25 mg/CAT, 100 mg/
            3.6-5.0                       20                      25
                                                                                      DOG IM or SQ before and for several days
            3.1-3.5                       28                      18                  after nutritional support implementation
            2.6-3.0                       40                      12                  in high-risk patients.
                                                                                  •  Use caution in return to feeding after pro-
            2.1-2.5                       60                      8
                                                                                    longed anorexia/starvation (e.g., start with
            <2.0                          80                      6                 20%-25% of RER or 5-10 kcal/kg/day).
                                                                                  •  Monitor electrolytes, blood gas, PCV/TS,
           *2 mEq/mL; do not exceed 0.5 mEq/kg/h.
           † Do not exceed 60 mEq/L concentration if infused through a peripheral vein.  ECG, BP, vital signs, and body weight daily.
           ‡ Administered as a continuous-rate infusion, never as a bolus.        •  Recognize  that  replacement  fluid  recom-
                                                                                    mendations assume normal food intake; ill
                                                                                    and hospitalized animals often are anorexic
           •  Red blood cell transfusions in cases of severe   parenteral thiamin supplementation to address   and may require less fluid supplementation.
             anemia                            probable poor thiamin status.
           •  Address electrolyte deficits according to the                       Technician Tips
             following recommendations for intravenous   Possible Complications   •  Daily physical exams by the technical staff
             electrolyte supplementation in refeeding   •  Fluid overload           are critical.
             syndrome.                         •  Heart failure                   •  Recognize that these are fragile patients and
           •  The trends of change are more important   •  Arrhythmias              acute deteriorations in clinical status occur.
             than the absolute lab values.     •  Hypoventilation                 •  Encourage and support veterinarians in the
           •  Address the electrolyte deficits early, ideally   •  Hemolytic anemia  use of central lines and frequent monitoring.
             before becoming clinically significant.  •  Generalized weakness     •  Discourage use of forced syringe feeding.
           •  Relatively fluid intolerant: monitor fluid ins   •  Neurologic alterations  •  Practice comprehensive excellent nursing care,
             and outs closely.                 •  Death                             including grooming and ensuring patient
                                                                                    comfort.
           Chronic Treatment                   Recommended Monitoring
           •  Slow  increase  in  delivered  calories  until   •  Body weight measured daily  SUGGESTED READING
             normal intake resumes.            •  Packed cell volume (PCV)/total solids (TS),   Khan LUR, et al: Refeeding syndrome: a literature
           •  The more severe the abnormalities, the more   glucose, and electrolyte concentrations q 4-6h   review. Gastroenterol Res Pract 1–6, 2011. doi:
             gradual caloric increases should be.  until normalized, then daily during oral or   10.1155/2011/410971.
           •  The  length  of  time  from  introduction  of   parenteral feeding until RER is met and well
             calories to RER may be 5-10 days.  tolerated                         ADDITIONAL SUGGESTED
                                               •  Serum phosphorus daily for first 5 days or
           Nutrition/Diet                       if there is a change in PCV       READINGS
           No specific diet can prevent this syndrome.   •  Venous blood gases q 6-12h until cardio-  Armitage-Chan EA, et al: Management of prolonged
           The amount and rate of caloric intake result   vascular stability is achieved, then every 24   food  deprivation,  hypothermia,  and  refeeding
           in electrolyte and fluid shifts in susceptible   hours until RER is met  syndrome in a cat. J Vet Emerg Crit Care 16(suppl
                                                                                   1):S34-S41, 2006.
           patients. Diets lower in carbohydrates and   •  Must closely monitor cardiovascular system   Bateman S: Disorders of magnesium: magnesium
           higher in protein and fat may be warranted   (electrocardiogram [ECG] and blood pres-  deficit and excess. In DiBartola SP, editor: Fluid
           in  at-risk  patients  without  contraindications   sure) during therapy  therapy in small animal practice, ed 3, St. Louis,
           to this nutritional profile. Consider short-term                        2006, Saunders, p 210.

                                                      www.ExpertConsult.com
   1730   1731   1732   1733   1734   1735   1736   1737   1738   1739   1740